VEGFA and neoplasm: Moreover, the main trunk blood vessels of SFVNs would not be expected to respond to anti-VEGF treatment, whereas a terminal tangle of new vessels adjacent to edge of tumor is likely to respond, which may be attributed to the regression of SRF.